These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 33254355)

  • 21. Efficacy of cidofovir versus bevacizumab in recurrent respiratory papillomatosis: A randomized, double-blind, placebo-controlled pilot study.
    Ablanedo-Terrazas Y; Estrada-Camacho O; Alvarado-de la Barrera C; Ramírez-García A; Tona-Acedo G; Bross-Soriano D; Schimelmitz-Idi J
    Acta Otorrinolaringol Esp (Engl Ed); 2022; 73(2):82-88. PubMed ID: 35397828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systematic review of the use of human papillomavirus vaccine as adjuvant therapy for juvenile-onset recurrent respiratory papillomatosis.
    Park I; Carbone S; Preciado D
    Int J Pediatr Otorhinolaryngol; 2022 Nov; 162():111314. PubMed ID: 36116179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of recurrent respiratory papillomatosis: role of HPV vaccination.
    Freed GL; Derkay CS
    Int J Pediatr Otorhinolaryngol; 2006 Oct; 70(10):1799-803. PubMed ID: 16884786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human papillomatosis genotyping and severity in patients with recurrent respiratory papillomatosis.
    Intakorn P; Sonsuwan N
    J Med Assoc Thai; 2014 Jun; 97 Suppl 6():S136-41. PubMed ID: 25391185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Squamous Cell Papillomatosis in the Setting of Recurrent Respiratory Papillomatosis.
    Bentley PL; Coulter MJ; Nelson BL
    Head Neck Pathol; 2019 Jun; 13(2):235-238. PubMed ID: 29594918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment With Quadrivalent Human Papillomavirus Vaccine for Juvenile-Onset Recurrent Respiratory Papillomatosis: Case Report and Review of the Literature.
    Katsuta T; Miyaji Y; Offit PA; Feemster KA
    J Pediatric Infect Dis Soc; 2017 Nov; 6(4):380-385. PubMed ID: 28992265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spontaneous Regression of Recurrent Respiratory Papillomatosis with HPV Vaccination: A Case Study.
    Nyirjesy S; Osmundson P; Matrka L
    J Voice; 2022 Jul; 36(4):587.e21-587.e25. PubMed ID: 32891477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Infantile recurrent respiratory papillomatosis: review of adjuvant therapies.
    Patel A; Orban N
    J Laryngol Otol; 2021 Nov; 135(11):958-963. PubMed ID: 34470689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunological tolerance of low-risk HPV in recurrent respiratory papillomatosis.
    Ivancic R; Iqbal H; deSilva B; Pan Q; Matrka L
    Clin Exp Immunol; 2020 Feb; 199(2):131-142. PubMed ID: 31628850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aggressive recurrent respiratory papillomatosis: A series of five consecutive patients successfully treated with adjuvant intravenous bevacizumab. A single Belgian academic center experience.
    Collette F; Lawson G; Hassid S; Delahaut G; Bachy V; Van Der Vorst S; Faugeras L; Gilliaux Q; D'Hondt L
    Head Neck; 2023 May; 45(5):1071-1079. PubMed ID: 36840929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implementation of Routine HPV Vaccination in the Management of Recurrent Respiratory Papillomatosis.
    Yiu Y; Fayson S; Smith H; Matrka L
    Ann Otol Rhinol Laryngol; 2019 Apr; 128(4):309-315. PubMed ID: 30595025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Photodynamic therapy for recurrent respiratory papillomatosis.
    Lieder A; Khan MK; Lippert BM
    Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD009810. PubMed ID: 24898010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic bevacizumab for recurrent respiratory papillomatosis.
    Baday YI; Ongkasuwan J; Venkatramani R
    Int J Pediatr Otorhinolaryngol; 2020 Nov; 138():110352. PubMed ID: 32906078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and clinical activity of PD-L1 blockade in patients with aggressive recurrent respiratory papillomatosis.
    Allen CT; Lee S; Norberg SM; Kovalovsky D; Ye H; Clavijo PE; Hu-Lieskovan S; Schlegel R; Schlom J; Strauss J; Gulley JL; Trepel J; Hinrichs CS
    J Immunother Cancer; 2019 May; 7(1):119. PubMed ID: 31053174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recurrent respiratory papillomatosis: a complex defect in immune responsiveness to human papillomavirus-6 and -11.
    Bonagura VR; Hatam LJ; Rosenthal DW; de Voti JA; Lam F; Steinberg BM; Abramson AL
    APMIS; 2010 Jun; 118(6-7):455-70. PubMed ID: 20553528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgical treatment and adjuvant therapies of recurrent respiratory papillomatosis.
    Avelino MA; Zaiden TC; Gomes RO
    Braz J Otorhinolaryngol; 2013; 79(5):636-42. PubMed ID: 24141682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Laryngeal Recurrent Respiratory Papillomatosis: Current Aspects on Diagnosis and Therapy].
    Langer C; Wittekindt C; Wolf G
    Laryngorhinootologie; 2019 Aug; 98(8):577-587. PubMed ID: 31387134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human papillomavirus types causing recurrent respiratory papillomatosis in Zimbabwe.
    Matinhira N; Soko ND; Bandason T; Jenson RG; Dzongodza T; von Buchwald C; Chidziva C
    Int J Pediatr Otorhinolaryngol; 2019 Jan; 116():147-152. PubMed ID: 30554686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tracheal papillomatosis: what do we know so far?
    Harris K; Chalhoub M
    Chron Respir Dis; 2011; 8(4):233-5. PubMed ID: 21971565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intersurgical interval increased with use of quadrivalent human papillomavirus vaccine (Gardasil) in a pediatric patient with recurrent respiratory papillomatosis: A case report.
    Baumanis MM; Elmaraghy CA
    Int J Pediatr Otorhinolaryngol; 2016 Dec; 91():166-169. PubMed ID: 27863633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.